| DC Field | Value | Language |
|---|
| dc.contributor.author | Kukes, V. G. | - |
| dc.contributor.author | Gorbach, T. V. | - |
| dc.contributor.author | Romashchenko, O. V. | - |
| dc.contributor.author | Rumbesht, V. V. | - |
| dc.date.accessioned | 2022-05-05T09:19:27Z | - |
| dc.date.available | 2022-05-05T09:19:27Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | АТP as the marker of power exchange condition at the experimental ischemia of the myocardium due to metabolic drugs introduction / V. G. Kukes [et al.] // Research result: pharmacology and clinical pharmacology. - 2016. - Vol. 2, № 3.- P. 58-62. - Doi: 10.18413/2500-235X -2016-2-3-58-62. - Refer.: p. 61-62. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46616 | - |
| dc.description.abstract | For the purpose of definition of an adequate marker of a power exchange condition at the experimental ischemia of the myocardium due introduction of metabolic drugs, the experimental research on 60 rats-males of Wistar line has been spent. At experimental myocardial ischemia it has been found out energy-saving effects of trimetazidine, cytoflavin, meldonium, phosphocreatine, which were reached by different ways and in different degree | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | ATP | ru |
| dc.subject | myocardial metabolism | ru |
| dc.subject | cardiocytoprotection | ru |
| dc.subject | energy-saving effect | ru |
| dc.subject | metabolic drugs | ru |
| dc.subject | trimetazidine | ru |
| dc.subject | meldonium | ru |
| dc.subject | cytoflavin | ru |
| dc.subject | phosphocreatine | ru |
| dc.title | АТP as the marker of power exchange condition at the experimental ischemia of the myocardium due to metabolic drugs introduction | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 2, № 3
|
